Try our Advanced Search for more refined results

K-V Discovery Solutions, Inc., et al., FN

Track this case

Case overview

Case Number:

1:12-bk-13346

Court:

New York Southern

Nature of Suit:

Firms

Companies

Government Agencies

Sectors & Industries:

  1. October 30, 2013

    K-V, Secured Lenders Reach $5M Deal To End Interest Row

    The reorganized K-V Pharmaceutical Co. on Tuesday reached a $5 million settlement with a group of senior secured lenders who had sued to obtain $34.7 million in additional interest on the debt they held.

  2. August 28, 2013

    Bankrupt K-V To Pay $24M To Settle FCA Suit

    A New York federal bankruptcy judge Wednesday approved a settlement in which K-V Discovery Solutions Inc. will pay roughly $23.8 million to settle a False Claims Act suit and pay for accompanying fines, shortly after K-V received the go-ahead for its Chapter 11 restructuring plan.

  3. August 28, 2013

    K-V Pharma Judge Greenlights Reorganization Plan

    K-V Pharmaceutical Co. on Wednesday received a bankruptcy judge's approval of its reorganization plan that will allow it to exit the Chapter 11 process and continue its business following a competitive bidding process.

  4. August 19, 2013

    K-V Creditors Slam Senior Bondholders' Bid For Interest

    Creditors of K-V Pharmaceutical Co. on Friday urged a New York bankruptcy judge to deny a group of senior bondholders' demand for post-petition interest on the debt they hold before convertible noteholders receive any payments.

  5. July 16, 2013

    K-V Pharma Gets Judge's Nod To Collect Ch. 11 Plan Votes

    K-V Pharmaceutical Co. can now begin soliciting creditor votes for its Chapter 11 restructuring plan after receiving the go-ahead from a New York bankruptcy judge Tuesday and months of bouncing back and forth between two competing groups of interested investors.

  6. July 08, 2013

    Silver Point Seeks Full Interest Payment In K-V Bankruptcy

    Silver Point Finance LLC and other senior noteholders in K-V Pharmaceutical Co.'s bankruptcy on Wednesday urged a New York bankruptcy judge to force the company to pay millions in accrued interest on a group of senior bonds.

  7. June 07, 2013

    K-V Judge Signs Off On Investors' $275M Plan

    The bidding war for K-V Pharmaceutical Co. drew to a close Friday as a New York bankruptcy judge approved a plan support agreement with a group of investors offering a $275 million plan to take over the women's health company and finance its exit from bankruptcy.

  8. May 31, 2013

    Battle For K-V Pharma Amps Up As Silver Point Boosts Offer

    A group of senior bondholders led by Silver Point Finance LLC on Friday upped their offer to take control of the bankrupt K-V Pharmaceutical Co. in response to a group of investors that raised the stakes by increasing their own proposal just days ago.

  9. May 29, 2013

    K-V Investor Group Bumps Up Ch. 11 Offer To $275M

    An investor group that has proposed a Chapter 11 plan that would allow it to take over K-V Pharmaceutical Co. upped its proposal to $275 million on Wednesday in New York bankruptcy court, once again raising the stakes for a group of senior bondholders who first sought to take over the company.

  10. May 29, 2013

    Bankrupt K-V Settles Texas Medicaid Fraud Suit For $3M Claim

    K-V Pharmaceutical Co. has agreed to hand Texas a $3 million unsecured claim in its bankruptcy to settle a whistleblower suit alleging the company made false claims to the state's Medicaid program, according to court documents filed Tuesday.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!